Inflammatory bowel diseases, interleukin-6 and interleukin-6 receptor subunit alpha in causal association with cerebral cortical structure: a Mendelian randomization analysis

炎症性肠病、白细胞介素-6及其受体亚基α与大脑皮层结构存在因果关系:一项孟德尔随机化分析

阅读:1

Abstract

BACKGROUND: Neurological involvement and psychiatric manifestations have been documented in clinical cases of inflammatory bowel disease (IBD); however, the presence of a causal relationship remains elusive. The objective of this study is to investigate the modifications occurring in the cerebral cortex as a result of IBD. METHODS: A compendium of data extracted from a genome-wide association study (GWAS) involving a maximum of 133,380 European subjects. A series of Mendelian random analyses were applied to exclude heterogeneity and pleiotropy, ensuring the stability of the results. RESULTS: Neither IBDs nor inflammatory cytokines (IL-6/IL-6Rα) were found to have a significant causality with surface area (SA) and thickness (TH) at the global level. At the regional functional brain level, Crohn's disease (CD) significantly decreased the TH of pars orbitalis (β=-0.003mm, Se=0.001mm, p(ivw) =4.85×10(-4)). IL-6 was observed to reduce the SA of middle temporal (β=-28.575mm(2), Se=6.482mm(2), p(ivw)=1.04×10(-5)) and increase the TH of fusiform (β=0.008mm, Se=0.002mm, p(ivw)=8.86×10(-5)) and pars opercularis (β=0.009mm, Se=0.002mm, p(ivw)=2.34×10(-4)). Furthermore, a causal relationship between IL-6Rα and an increase in the SA of superior frontal (β=21.132mm(2), Se=5.806mm(2), p(ivw)=2.73×10(-4)) and the TH of supramarginal (β=0.003mm, Se=0.0002mm, p(ivw)=7.86×10(-37)). All results passed sensitivity analysis and no heterogeneity and pleiotropy were detected. CONCLUSION: The correlation between IBD and changes in cerebral cortical structures implies the existence of a gut-brain axis at the organismal level. It is recommended that clinical patients with IBD prioritize long-term management of inflammation, as changes at the organismal level can lead to functional pathologies. Magnetic resonance imaging (MRI) may be considered as an additional screening option for IBD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。